缩写名/全名 |
CLIN CANCER RES
CLINICAL CANCER RESEARCH |
||||||||||||||||||||
ISSN号 | 1078-0432 | ||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
影响因子 | 2015:8.738, 2016:9.619, 2017:10.199, 2018:8.911, 2019:10.107, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Semimonthly | ||||||||||||||||||||
年文章数 | 672 | ||||||||||||||||||||
出版年份 | 1995 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均2.1月 |
||||||||||||||||||||
录用比例 | 约30% | ||||||||||||||||||||
投稿链接 | http://ccr.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||
投稿官网 | http://clincancerres.aacrjournals.org/ | ||||||||||||||||||||
h-index | 292 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1078-0432%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma. Author: Zhang JY#1, Zhang PP#1, Zhou WP#1, Yu JY2, Yao ZH1, Chu JF1, Yao SN1, Wang C2, Lone W2, Xia QX3, Ma J3, Yang SJ1, Liu KD4,5, Dong ZG4, Guo YJ3, Smith LM6, McKeithan TW7, Chan WC8, Iqbal J9, Liu YY10. Journal: Clin Cancer Res. 2019 Mar 1. doi: 10.1158/1078-0432.CCR-18-2146. [Epub ahead of print] PubMed DOI |
2. | Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity. Author: Jia X#1,2,3, Li C#2,3, Li L3, Liu X4, Zhou L3, Zhang W1,2, Ni S3, Lu Y3, Chen L1,2, Jeong LS5, Yu J5, Zhang Y6,7, Zhang J6,7, He S6,7, Hu X1,2, Sun H1,2, Yu K1,2, Liu G1,2, Zhao H8, Zhang Y8, Jia L9, Shao ZM10,2. Journal: Clin Cancer Res. 2019 Mar 4. doi: 10.1158/1078-0432.CCR-18-2434. [Epub ahead of print] PubMed DOI |
3. | Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial. Author: Xu J1, Li J2, Bai C3, Xu N4, Zhou Z5, Li Z6, Zhou C7, Jia R8, Lu M2, Cheng Y3, Mao C4, Wang W5, Cheng K6, Su C7, Hua Y9, Qi C9, Li J9, Wang W9,10, Li K9, Sun Q9, Ren Y9, Su W9. Journal: Clin Cancer Res. 2019 Mar 4. doi: 10.1158/1078-0432.CCR-18-2994. [Epub ahead of print] PubMed DOI |
4. | HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma. Author: Li H#1, Li J#1, Chen L#1, Qi S#1,2,3, Yu S4, Weng Z1, Hu Z5, Zhou Q1, Xin Z1, Shi L1, Ma L1, Huang A6, Lu Y7,2,3. Journal: Clin Cancer Res. 2019 Mar 12. doi: 10.1158/1078-0432.CCR-18-3791. [Epub ahead of print] PubMed DOI |
5. | PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Author: Chung EY1, Mai Y1, Shah UA2, Wei Y1,3, Ishida E1, Kataoka K4, Ren X5, Pradhan K6, Bartholdy B1, Wei X1,3, Zou Y2, Zhang J5, Ogawa S7, Steidl U1, Zang X5, Verma A2,5, Janakiram M2, Ye BH8. Journal: Clin Cancer Res. 2019 Mar 12. doi: 10.1158/1078-0432.CCR-18-3033. [Epub ahead of print] PubMed DOI |
6. | Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs. Author: Kiseleva AA1,2, Korobeynikov VA1,3, Nikonova AS1, Zhang P1,4, Makhov P5, Deneka AY1,2, Einarson MB1, Serebriiskii IG1,2, Liu H4, Peterson JR5, Golemis EA6. Journal: Clin Cancer Res. 2019 Mar 13. doi: 10.1158/1078-0432.CCR-18-3535. [Epub ahead of print] PubMed DOI |
7. | Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing. Author: Tian T#1, Lv X#2,3, Pan G#1,4, Lu Y#1, Chen W#1,4, He W5, Lei X1, Zhang H1, Liu M1, Sun S6, Ou Z1, Lin X1, Cai L7, He L7, Tu Z7, Wang X7, Tannous BA8, Ferrone S7, Li J9,4, Fan S9,4,7. Journal: Clin Cancer Res. 2019 Mar 18. doi: 10.1158/1078-0432.CCR-18-2739. [Epub ahead of print] PubMed DOI |
8. | The Caspase-3/PKCδ/Akt/VEGF-A Signaling Pathway Mediates Tumor Repopulation during Radiotherapy. Author: Cheng J#1, He S#1, Wang M2, Zhou L3, Zhang Z1, Feng X1, Yu Y1, Ma J4, Dai C5, Zhang S5, Sun L5, Gong Y1, Wang Y1, Zhao M1, Luo Y1, Liu X6, Tian L5, Li C7, Huang Q8. Journal: Clin Cancer Res. 2019 Mar 19. doi: 10.1158/1078-0432.CCR-18-3001. [Epub ahead of print] PubMed DOI |
9. | Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer. Author: Heigener DF1,2,3, Kerr KM4, Laing GM4, Mok TSK5, Moiseyenko FV6,7, Reck M8,9,3. Journal: Clin Cancer Res. 2019 Mar 25. doi: 10.1158/1078-0432.CCR-18-1894. [Epub ahead of print] PubMed DOI |
10. | CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC. Author: Liu Y1,2, Liu L1, Zhou Y1, Zhou P1, Yan Q1, Chen X3, Ding S1, Zhu F4,2,5. Journal: Clin Cancer Res. 2019 Mar 27. doi: 10.1158/1078-0432.CCR-18-3510. [Epub ahead of print] PubMed DOI |
|
|